# Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing

> **NCT06028282** · — · UNKNOWN · sponsor: **State University of New York - Upstate Medical University** · enrollment: 10 (estimated)

## Conditions studied

- Thyroid Disease

## Interventions

- **RADIATION:** SPECT

## Key facts

- **NCT ID:** NCT06028282
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-08
- **Primary completion:** 2024-11-08
- **Final completion:** 2025-06-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06028282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06028282, "Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06028282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
